Davendra Sohal, MD, MPH
Case Comprehensive Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Davendra Sohal, MD, MPH as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:31 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT02383433 · Regorafenib Plus Gemcitabine in Metastatic Pancreatic CancerCase Comprehensive Cancer Center · terminated · Metastatic Pancreatic Adenocarcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:31 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Cancer Genomics and EpigenomicsP30CA043703 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI Zhenghe Wang · fiscal years 2009 to 2026Named on NCT02383433
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in pancreatic cancer.